NCT03580512

Brief Summary

This will be a prospective study that will enroll up to 2000 MSM and TG from community-based clinics in Bangkok, Chonburi, Chiang Mai, and Songkhla.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 9, 2018

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 26, 2022

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

5.5 years

First QC Date

May 31, 2018

Last Update Submit

November 22, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Proportion of participants who receive same-day diagnosis and treatment of CT/NG in community-based clinics

    1 years

  • Proportion of participants who receive same-day diagnosis of HIV infection in community-based clinics

    1 years

Study Arms (3)

Group 1

\- 800 existing clients who already received PrEP

Group 2

* 800 new clients who present for HIV testing and are HIV-negative. All will be offered PrEP * 600 clients who will refuse PrEP * 200 clients who will receive PrEP

Group 3

\- 400 new clients who are HIV-positive or new clients who present for HIV testing and are HIV-positive

Eligibility Criteria

Age18 Years+
Sexmale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Approximately 2000 MSM and TG

You may qualify if:

  • Thai nationality
  • Age ≥ 18 years old
  • Men or transgender women who have sex with men
  • Have at least one of the following risks for HIV acquisition in the past 6 months:
  • Any unprotected receptive anal sex
  • More than 5 sexual partners, regardless of condom use and serostatus
  • History of syphilis, chlamydia or gonorrhea diagnosed or treated
  • Any stimulant drug use
  • Have signed the consent form

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

1.Swing Dic,

Bangkok, Thailand

Location

2.Rsat Dic,

Bangkok, Thailand

Location

5. Mplus DIC,

Chiang Mai, Thailand

Location

3.Swing Dic

Chon Buri, Thailand

Location

4. Sisters DIC,

Chon Buri, Thailand

Location

6.Rsat Dic,

Songkhla, Thailand

Location

Related Publications (2)

  • Hiransuthikul A, Sungsing T, Jantarapakde J, Trachunthong D, Mills S, Vannakit R, Phanuphak P, Phanuphak N. Correlations of chlamydia and gonorrhoea among pharyngeal, rectal and urethral sites among Thai men who have sex with men: multicentre community-led test and treat cohort in Thailand. BMJ Open. 2019 Jun 27;9(6):e028162. doi: 10.1136/bmjopen-2018-028162.

  • Hiransuthikul A, Janamnuaysook R, Sungsing T, Jantarapakde J, Trachunthong D, Mills S, Vannakit R, Phanuphak P, Phanuphak N. High burden of chlamydia and gonorrhoea in pharyngeal, rectal and urethral sites among Thai transgender women: implications for anatomical site selection for the screening of STI. Sex Transm Infect. 2019 Nov;95(7):534-539. doi: 10.1136/sextrans-2018-053835. Epub 2019 Apr 13.

MeSH Terms

Conditions

Homosexuality

Condition Hierarchy (Ancestors)

SexualitySexual BehaviorBehavior

Study Officials

  • Nittaya Phanuphak, MD, PhD

    Thai Red Cross AIDS Research Centre (TRCARC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2018

First Posted

July 9, 2018

Study Start

April 15, 2017

Primary Completion

October 26, 2022

Study Completion

March 15, 2024

Last Updated

November 25, 2024

Record last verified: 2024-11

Locations